Related Experiment Video
Updated: Aug 17, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Coccidioidomycosis in renal replacement therapy
Abstract:
The potential risk of coccidioidomycosis has led to concern about the advisability of maintaining renal transplantation programs in endemic areas. We reviewed the charts of 721 patients undergoing dialysis and 260 renal transplant recipients in Arizona to determine the incidence, risk factors, and clinical course of coccidioidomycosis in these immunosuppressed populations. Symptomatic infection occurred in six (0.83%) patients undergoing dialysis and 18 (6.9%) transplant recipients. Male sex and blood type B predisposed to dissemination. Urine cultures for fungus were important diagnosis aids. Four of six patients with infection limited to the thorax and five of 18 patients with dissemination remained alive after seven months to 7 1/2 years. Although the rate of dissemination (75%) and mortality (63%) from coccidioidomycosis were high, the incidence of infection was low and does not preclude renal transplantation in Arizona. Those who have received transplants elsewhere should be advised not to move or to visit areas endemic for coccidioidomycosis.
Insights
Coccidioidomycosis risk in Arizona renal transplant patients is low, with only 6.9% experiencing symptomatic infection. Male sex and blood type B increased dissemination risk, but transplantation remains viable in endemic areas.
Area of Science:
- Nephrology
- Infectious Diseases
- Mycology
Background:
- Renal transplantation in coccidioidomycosis-endemic areas raises safety concerns.
- Immunosuppressed populations are at higher risk for fungal infections.
Purpose of the Study:
- To determine coccidioidomycosis incidence and risk factors in dialysis and renal transplant patients in Arizona.
- To analyze the clinical course and outcomes of coccidioidomycosis in these patient groups.
Main Methods:
- Retrospective chart review of 721 dialysis patients and 260 renal transplant recipients.
- Analysis of symptomatic infection rates, risk factors (sex, blood type), and diagnostic methods (urine fungal cultures).
Main Results:
- Symptomatic coccidioidomycosis occurred in 0.83% of dialysis patients and 6.9% of transplant recipients.
- Male sex and blood type B were associated with dissemination.
- Urine fungal cultures proved valuable for diagnosis.
- Mortality was high (63%) in disseminated cases, but survival was possible.
Conclusions:
- The low incidence of coccidioidomycosis does not contraindicate renal transplantation in Arizona.
- Patients with existing transplants should avoid endemic areas.
- Risk stratification and careful monitoring are crucial for immunosuppressed patients in endemic regions.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Cryptococcal Meningitis